NetworkNewsBreaks – Earth Science Tech, Inc. (ET
Post# of 333
(Total Views: 251)
Posted On: 01/25/2018 8:21:38 PM
NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Reaches Noteworthy Achievements in 2017
Earth Science Tech, Inc. (OTC: ETST) is an innovative biotech company focused on production of cutting-edge industrial hemp and cannabidiol (“CBD”) products. An article discussing the company reads: “Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Earth Science Tech, Inc. (OTC: ETST) is an innovative biotech company focused on production of cutting-edge industrial hemp and cannabidiol (“CBD”) products. An article discussing the company reads: “Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)